Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Brain metabolic sensing and metabolic signaling at the level of an astrocyte
Vitamin E nanoparticles, based on an MMP2/ROS-sensitive mechanism, achieve responsive release of vitamin E in high ROS environments, scavenging lipid radicals and blocking the ferroptosis cascade, thereby effectively improving IRI-related oxidative stress and renal dysfunction [90]
Key Market Segments Product Type Semaglutide Liraglutide Exenatide Dulaglutide Others Route of Administration Parenteral Oral Application Type 2 diabetes mellitus Obesity Others Distribution Channel Hospital pharmacies Online pharmacies Retail pharmacies Drivers Increasing Global Prevalence of Type 2 Diabetes Mellitus and Obesity is Driving the Market The escalating global prevalence of type 2 diabetes mellitus and obesity is a major driver for the GLP-1 Receptor Agonist Market
Drugs 8 , 105116 (2007)
US$ 23.72
US$ 20.13
US$ 27.78
US$ 28.66
US$ 28.60
